Hit enter to search or ESC to close
Cortexyme
  • Home
  • Team
  • Pipeline
  • Science
  • News
  • Investors
  • Careers
Cortexyme
All Posts By

MacKenzie Lahar

News

Cortexyme Announces Pipeline Update and Anticipated 2022 Milestones

By MacKenzie Lahar | News
News

Cortexyme Announces Change in Executive Leadership Team

By MacKenzie Lahar | News
News

Cortexyme Announces Clinical Hold on Atuzaginstat’s Investigational New Drug Application

By MacKenzie Lahar | News
EventsNews

Cortexyme’s Atuzaginstat Slowed Cognitive Decline in Participants with Alzheimer’s Disease and P. Gingivalis Infection in Phase 2/3 GAIN Trial: Additional Top-line Data Presented at CTAD 2021

By MacKenzie Lahar | Events, News
EventsNews

Cortexyme Reports GAIN Trial Data Demonstrated Relationship Between Reduction of P. gingivalis Infection and Slowing of Alzheimer’s Disease Progression

By MacKenzie Lahar | Events, News

Please note our Privacy Policy and Terms of Use. ©2022 Cortexyme

  • Home
  • Team
  • Pipeline
  • Science
  • News
  • Investors
  • Careers